(19)
(11) EP 3 906 234 A1

(12)

(43) Date of publication:
10.11.2021 Bulletin 2021/45

(21) Application number: 20701499.4

(22) Date of filing: 02.01.2020
(51) International Patent Classification (IPC): 
C07D 401/14(2006.01)
A61K 31/495(2006.01)
A61P 35/00(2006.01)
A61K 31/4709(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 401/14; A61P 35/00
(86) International application number:
PCT/IB2020/050009
(87) International publication number:
WO 2020/141470 (09.07.2020 Gazette 2020/28)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 03.01.2019 US 201962787965 P
07.06.2019 US 201962858819 P
13.12.2019 US 201962947720 P

(71) Applicant: Array BioPharma Inc.
Boulder, CO 80301 (US)

(72) Inventors:
  • COOK, Adam
    Boulder, CO 80301 (US)
  • HINKLIN, Ronald Jay
    Boulder, CO 80301 (US)
  • MCNULTY, Oren T.
    Boulder, CO 80301 (US)

(74) Representative: Pfizer 
European Patent Department 23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)

   


(54) QUINOLINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES